Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. (Q53122367)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

ulcerative colitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

22

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Martti Färkkilä

23

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Javier P Gisbert

24

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

object named as

Maria Nachury

9

0 references

Gert Van Assche

21

object named as

Gert Van Assche

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

Jean-Frédéric Colombel

30

object named as

Jean-Frederic Colombel

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

author name string

David Laharie

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Arnaud Bourreille

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Julien Branche

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Matthieu Allez

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Yoram Bouhnik

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jerome Filippi

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Frank Zerbib

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Guillaume Savoye

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jacques Moreau

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jean-Charles Delchier

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jacques Cosnes

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Elena Ricart

13

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Olivier Dewit

14

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Antonio Lopez-Sanroman

15

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jean-Louis Dupas

16

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Franck Carbonnel

17

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Gilles Bommelaer

18

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Benoit Coffin

19

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Xavier Roblin

20

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Philippe Marteau

25

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Stephane Nahon

26

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Martine de Vos

27

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Denis Franchimont

28

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Jean-Yves Mary

29

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Marc Lémann

31

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives

32

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

language of work or name

0 references

publication date

10 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

380

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

9857

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

1909-1915

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The pattern and outcome of acute severe colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

European evidence-based Consensus on the management of ulcerative colitis: Current management

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Power and sample size calculations. A review and computer program

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab efficacy in pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(12)61084-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61084-8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23063316

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53122367&oldid=1578270122"